The tick salivary protein, Salp15, inhibits the development of experimental asthma

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7064-7071

  Paveglio, Sara A ^a   Allard, Jenna ^a   Mayette, Jana ^a   Whittaker, Laurie A ^a   Juncadella, Ignacio ^b   Anguita, Juan ^b   Poynter, Matthew E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 2; OVALBUMIN; PROTEIN SALP1; SALIVA PROTEIN; UNCLASSIFIED DRUG;

AEROSOL; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHILIA; FEMALE; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; IXODES SCAPULARIS; METAPLASIA; MOUSE; NONHUMAN; PARASITISM; PREVALENCE; PRIORITY JOURNAL; PROTEIN SECRETION; SENSITIZATION; T LYMPHOCYTE ACTIVATION; TH2 CELL; TICK;

EID: 34249810647     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7064     Document Type: Article

References (42)

1. Eder, W., M. J. Ege, and E. von Mutius. 2006. The asthma epidemic. N. Engl. J. Med. 355: 2226-2235.
2. Schaub, B., R. Lauener, and E. von Mutius. 2006. The many faces of the hygiene hypothesis. J. Allergy Clin. Immunol. 117: 969-977.
3. Mazzarella, G., A. Bianco, E. Catena, R. De Palma, and G. F. Abbate. 2000. Th1/Th2 lymphocyte polarization in asthma. Allergy 55(Suppl. 61): 6-9.
4. Taube, C., A. Dakhama, and E. W. Gelfand. 2004. Insights into the pathogenesis of asthma utilizing murine models. Int. Arch. Allergy Immunol. 135: 173-186.
5. Yeung, V. P., R. S. Gieni, D. T. Umetsu, and R. H. DeKruyff. 1998. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J. Immunol. 161: 4146-4152.
6. Hopfenspirger, M. T., and D. K. Agrawal. 2002. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J. Immunol. 168: 2516-2522.
7. Rodriguez, D., A. C. Keller, E. L. Faquim-Mauro, M. S. de Macedo, F. Q. Cunha, J. Lefort, B. B. Vargaftig, and M. Russo. 2003. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J. Immunol. 171: 1001-1008.
8. Hayashi, T., L. Beck, C. Rossetto, X. Gong, O. Takikawa, K. Takabayashi, D. H. Broide, D. A. Carson, and E. Raz. 2004. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J. Clin. Invest. 114: 270-279.
9. Kitagaki, K., T. R. Businga, D. Racila, D. E. Elliott, J. V. Weinstock, and J. N. Kline. 2006. Intestinal helminths protect in a murine model of asthma. J. Immunol. 177: 1628-1635.
10. Krieg, A. M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5: 471-484.
11. Wikel, S. K. 1996. Host immunity to ticks. Annu. Rev. Entomol. 41: 1-22.
12. Binnington, K. C., and D. H. Kemp. 1980. Role of tick salivary glands in feeding and disease transmission. Adv. Parasitol. 18: 315-339.
13. Garg, R., I. J. Juncadella, N. Ramamoorthi, Ashish, S. K. Ananthanarayanan, V. Thomas, M. Rincon, J. K. Krueger, E. Fikrig, C. M. Yengo, and J. Anguita. 2006. Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J. Immunol. 177: 6579-6583.
14. Juncadella, I. J., R. Garg, S. K. Ananthnarayanan, C. M. Yengo, and J. Anguita. 2007. T-cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15. FEMS Immunol. Med. Microbiol. 49: 433-438.
15. + T cell activation. Immunity 16: 849-859.
16. Poynter, M. E., R. Cloots, T. van Woerkom, K. J. Butnor, P. Vacek, D.J. Taatjes, C. G. Irvin, and Y. M. Janssen-Heininger. 2004. NF-κB activation in airways modulates allergic inflammation but not hyperresponsiveness. J. Immunol. 173: 7003-7009.
17. Tomioka, S., J. H. Bates, and C. G. Irvin. 2002. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J. Appl. Physiol. 93: 263-270.
18. Lundblad, L. K., J. Thompson-Figueroa, T. Leclair, M. J. Sullivan, M. E. Poynter, C. G. Irvin, and J. H. Bates. 2005. Tumor necrosis factor-α overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 171: 1363-1370.
19. Takeda, K., E. Hamelmann, A. Joetham, L. D. Shultz, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186: 449-454.
20. Poynter, M., C. Irvin, and Y. Janssen-Heniniger. 2002. Rapid activation of nuclear factor-κB in airway epithelium in a murine model of allergic airway inflammation. Am. J. Pathol. 160: 1325-1334.
21. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, et al. 1983. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol. Rev. 74: 29-56.
22. Jones, B. 1983. Evidence that the Thy-1 molecule is the target for T cell mitogenic antibody against brain-associated antigens. Eur. J. Immunol. 13: 678-684.
23. Cohn, L., R. J. Homer, H. MacLeod, M. Mohrs, F. Brombacher, and K. Bottomly. 1999. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J. Immunol. 162: 6178-6183.
24. Woerly, G., N. Roger, S. Loiseau, and M. Capron. 1999. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int. Arch. Allergy Immunol. 118: 95-97.
25. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
26. Severinson, E., P. Sideras, and S. Bergstedt-Lindqvist. 1987. IgG1 induction factor. Int. Rev. Immunol. 2: 143-156.
27. Coffman, R. L., H. F. Savelkoul, and D. A. Lebman. 1989. Cytokine regulation of immunoglobulin isotype switching and expression. Semin. Immunol. 1: 55-63.
28. Jurado, A., J. Carballido, H. Griffel, H. K. Hochkeppel, and G. D. Wetzel. 1989. The immunomodulatory effects of interferon-γ on mature B-lymphocyte responses. Experientia 45: 521-526.
29. Wagers, S. S., H. C. Haverkamp, J. H. Bates, R. J. Norton, J. A. Thompson-Figueroa, M. J. Sullivan, and C. G. Irvin. 2007. Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J. Appl. Physiol. 102: 221-230.
30. Ramamoorthi, N., S. Narasimhan, U. Pal, F. Bao, X. F. Yang, D. Fish, J. Anguita, M. V. Norgard, F. S. Kantor, J. F. Anderson, et al. 2005. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436: 573-577.
31. Rempel, J. D., M. Wang, and K. T. HayGlass. 1997. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production. J. Immunol. 159: 1490-1496.
32. Wagers, S., R. Norton, J. Bates, and C. G. Irvin. 2003. Role of fibrin in determining airway closure. Chest 123: 362S-363S.
33. Markwardt, F., J. Sturzebecher, and E. Glusa. 1990. Antithrombin effects of native and recombinant hirudins. Biomed. Biochim. Acta 49: 399-404.
34. Gabazza, E. C., O. Taguchi, S. Tamaki, H. Takeya, H. Kobayashi, H. Yasui, T. Kobayashi, O. Hataji, H. Urano, H. Zhou, et al. 1999. Thrombin in the airways of asthmatic patients. Lung 177: 253-262.
35. Panettieri, R. A., Jr., I. P. Hall, C. S. Maki, and R. K. Murray. 1995. α-thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 13: 205-216.
36. Terada, M., E. A. Kelly, and N. N. Jarjour. 2004. Increased thrombin activity after allergen challenge: a potential link to airway remodeling? Am. J. Respir. Crit. Care Med. 169: 373-377.
37. Pedra J. H., S. Narasimhan, K. Deponte, N. Marcantonio, F. S. Kantor, and E. Fikrig. 2006. Disruption of the salivary protein 14 in Ixodes scapularis nymphs and impact on pathogen acquisition. Am. J. Trop. Med. Hyg. 75: 677-682.
38. Paesen, G. C., P. L. Adams, K. Harlos, P. A. Nuttall, and D. I. Stuart. 1999. Tick histamine-binding proteins: isolation, cloning, and three-dimensional structure. Mol. Cell 3: 661-671.
39. Couillin, I., I. Maillet, B. B. Vargaftig, M. Jacobs, G. C. Paesen, P. A. Nuttall, J. Lefort, R. Moser, W. Weston-Davies, and B. Ryffel. 2004. Arthropod-derived histamine-binding protein prevents murine allergic asthma. J. Immunol. 173: 3281-3286.
40. Das, S., G. Banerjee, K. DePonte, N. Marcantonio, F. S. Kantor, and E. Fikrig. 2001. Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J. Infect. Dis. 184: 1056-1064.
41. Andreadis, A. A., S. L. Hazen, S. A. Comhair, and S. C. Erzurum. 2003. Oxidative and nitrosative events in asthma. Free Radical Biol. Med. 35: 213-225.
42. Tse, H. M., M. J. Milton, S. Schreiner, J. L. Profozich, M. Trucco, and J. D. Piganelli. 2007. Disruption of innate-mediated proinflammatory cytokine and reactive oxygen species third signal leads to antigen-specific hyporesponsiveness. J. Immunol. 178: 908-917.